根治性手术治疗不同Child-Pugh分级的肝泡型包虫病患者疗效研究

doi:10.3969/j.issn.1672-5069.2022.03.033

摘要/Abstract

摘要： 目的观察采取根治性手术治疗不同Child-Pugh分级的肝泡型包虫病患者的疗效。方法 2014年7月～2019年7月我院诊治的肝泡型包虫病患者60例,入院时Child-Pugh A级36例,B级24例。所有患者均接受根治性手术治疗,术后随访3年。结果在术后1 w,Child-Pugh A级患者血清总胆红素和碱性磷酸酶水平分别为(17.8±6.6)μmol/L和(80.0±21.5)U/L,显著低于Child-Pugh B级组【分别为(21.8±7.4)μmol/L和(97.8±17.9)U/L,P＜0.05】;术后,Child-Pugh A级组切口感染、胸腔积液、深静脉血栓、肝性脑病、难治性腹水、胆汁漏和肾功能不全发生率为30.6%,显著低于Child-Pugh B级组的79.2%(P＜0.05);36例Child-Pugh A级患者失访3例,Child-Pugh B级失访2例;Child-Pugh A级组1 a生存率为97.0%(32/33),3 a生存率为93.9%(31/33),而Child-Pugh B级组分别为90.9%(20/22)和86.4%(19/22),经Kaplan-Meier生存分析显示两组生存率无显著性差异(Log-Rank=8.99,P=0.343);随访期间,Child-Pugh A级组肝包虫病复发率为12.1%(4/33),Child-Pugh B级组复发率为27.3%(6/22,x²=1.146,P=0.284)。结论采取根治性手术治疗肝泡型包虫病患者存在一定的术后疾病复发率,而术前肝功能纠正很重要,可以减少术后并发症的发生。

关键词: 肝泡型包虫病, 根治性手术, Child-Pugh分级, 并发症, 复发

Abstract: Objective The aim of this study was to observe the long-term efficacy of radical surgery for treatment of patients with hepatic alveolus echinococcosis. Methods A total of 60 patients with hepatic alveolus echinococcosis (Child-Pugh class A in 36 cases, and class B in 24 cases) were encountered in our hospital between July 2014 and July 2019, and all underwent radical resection of the diseased foci. The patients were followed-up for 3 years. Results One week after operation, total serum bilirubin and alkalinephosphatase levels in patients with Child-Pugh class A were (17.8±6.6)μmol/L and (80.0±21.5)U/L, both significantly lower than [(21.8±7.4)μmol/L and (97.8±17.9)U/L, respectively, P＜0.05] in patients with Child-Pugh class B; the incidences of post-operational complications such as Incisional infection, pleural effusion, deep venous thrombosis, hepatic encephalopathy, refractory ascites, bile leak and renal deficiency in patients with Child-Pugh class A was 30.6%, significantly lower than 79.2%(P＜0.05) in patients with Child-Pugh class B; during three year follow-up period, three and two patients missed in patients with Child-Pugh class A and class B, respectively; the one-year and three-year survival in patients with Child-Pugh class A were 97.0%(32/33) and 93.9% (31/33), not significantly different compared to 90.9%(20/22) and 86.4%(19/22) in patients with Child-Pugh class B (Log-Rank=8.99, P=0.343); the hepatic foci relapse rate in patients with Child-Pugh class A was 12.1%(4/33), also not significantly different compared to 27.3%(6/22, x²=1.146, P=0.284) in patients with Child-Pugh class B. Conclusion Radical surgery is efficacious in treatment of patients with hepatic alveolus echinococcosis, even though with a relative high relapse post-operationally. The improvement of liver functions before operation is of very importance in order to decrease the post-operational complications.

Key words: Hepatic alveolar echinococcosis, Radical surgery, Child-Pugh grading, Complications, Relapse

贺伟, 刘贤国, 王刚, 卢建利, 叶智. 根治性手术治疗不同Child-Pugh分级的肝泡型包虫病患者疗效研究[J]. 实用肝脏病杂志, 2022, 25(3): 435-438.

He Wei, Liu Xianguo, Wang Gang, et al. Radical surgery for treatment of patients with hepatic alveolus echinococcosis[J]. Journal of Practical Hepatology, 2022, 25(3): 435-438.

参考文献

[1] Wang T, Yang XW, Wang W . Another case of hepatic alveolar echinococcosis? Asian J Surg, 2020, 43(11):1119-1120.
[2] Azizi A, Blagosklonov O, Lounis A, et al. Alveolar echinococcosis: Correlation between hepatic MRI findings and fdg-PET/CT metabolic activity. Abdom Imaging, 2015, 40(1):56-63.
[3] 董建, 杨凌菲, 张文宝,等. 新疆巴音布鲁克奎克乌苏达板地区2014年绵羊肝囊型包虫病现患率调查. 中华流行病学杂志, 2015, 36(2):136-138.
[4] Joliat GR, Melloul E, Petermann D, et al. Outcomes after liver resection for hepatic alveolar echinococcosis: A single-center cohort study. World J Surg, 2015, 39(10):2529-2534.
[5] Kratzer W, Gruener B, Kaltenbach TE, et al. Proposal of an ultrasonographic classification for hepatic alveolar echinococcosis: Echinococcosis multilocularis ulm classification-ultrasound. World j gastroenterol, 2015, 21(43):12392-12402.
[6] Tuxun T, Apaer S, Ma HZ, et al. The potential role of th9 cell related cytokine and transcription factors in patients with hepatic alveolar echinococcosis. J Immunol Res, 2015, 2015(2):1-7.
[7] 张长坤, 张龙辉, 王东,等. 术前肝功能Child-Pugh评分与白蛋白-胆红素评分对肝癌患者肝切除术后肝衰竭和预后的预测价值. 中华消化外科杂志, 2018, 17(5):474-482.
[8] Graeter T, Bao HH, Shi R, et al. Evaluation of intrahepatic manifestation and distant extrahepatic disease in alveolar echinococcosis. World J Gastroenterol, 2020, 26(29):4302-4315.
[9] 中国医师协会外科医师分会包虫病外科专业委员会. 肝两型包虫病诊断与治疗专家共识(2015年版).中华消化外科杂志, 2015, 14(4):253-264.
[10] Chen KF, Tang YY, Wang R, et al. The chose of different surgical therapies of hepatic alveolar echinococcosis: A single-center retrospective case-control study. Medicine, 2018, 97(8):1-5.
[11] Qiu Y, Yang XW, Shen S, et al. Vascular infiltration-based surgical planning in treating end-stage hepatic alveolar echinococcosis with ex vivo liver resection and autotransplantation. Surgery, 2019, 165(5):889-896.
[12] Ozturk G, Oral A, Aydinli B, et al. Two-yr follow-up of a 12-yr-old girl after living donor liver transplantation due to hepatic alveolar echinococcosis. Pediatr Transplant, 2015, 19(6):663-664.
[13] Ran B, Shao YM, Jiang TM, et al. Resection of retrohepatic inferior vena cava without reconstruction for hepatic alveolar echinococcosis. Chin Med J, 2019, 132(13):1623-1624.
[14] Beldi G, Vuitton D, Lachenmayer A, et al. Is ex vivo liver resection and autotransplantation a valid alternative treatment for end-stage hepatic alveolar echinococcosis in Europe? J Hepatol, 2019, 70(5):1030-1031.
[15] Li YP, Ma ZG, Tuxun T, et al. The application of laparoscopy combined with indocyanine green fluorescence imaging technique for hepatic cystic echinococcosis. BMC Surg, 2020, 20(1):249-249.
[16] 王文涛, 杨闯, 严律南. 肝泡型包虫病外科根治性治疗的新理念与策略. 中华医学杂志, 2018, 98(38):3049-3051.
[17] Magistri P, Pecchi A, Franceschini E, et al. Not just minor resections: Robotic approach for cystic echinococcosis of the liver. Infection, 2019, 47(6):1-7.
[18] Kawamura N, Kamiyama T, Sato N, et al. Long-term results of hepatectomy for patients with alveolar echinococcosis: A single-center experience. J Am Coll Surg, 2011, 212(5):804-812.
[19] Kim TH, Um SH, Yim SY, et al. The risk of perioperative adverse events in patients with chronic liver disease. Liver Int, 2015, 35(3):713-723.
[20] 刘琴, 罗艳丽, 肖凤鸣,等. 乙型肝炎肝硬化门脉高压症行脾切除联合门奇静脉断流术后影响预后的因素分析. 实用肝脏病杂志, 2017, 20(6):769-770.
[21] Xu LN, Yang B, Li GP, et al. Assessment of complications after liver surgery: Two novel grading systems applied to patients undergoing hepatectomy. J Huazhong Univ Sci Tech Med Sci, 2017, 37(3):352-356.